TY - JOUR
T1 - An index of fatal toxicity for new psychoactive substances
AU - King, L.A.
AU - Corkery, John
N1 - The final, definitive version of this paper has been published in Journal of Psychopharmacology, February 2018, published by SAGE Publishing, All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - An index of fatal toxicity for new psychoactive substances has been developed based solely on information provided on death certificates. An updated index of fatal toxicity (T
f), as first described in 2010, was calculated based on the ratio of deaths to prevalence and seizures for the original five substances (amphetamine, cannabis, cocaine/crack, heroin and 3,4-methylenedioxymethylamphetamine)
*. These correlated well with the 2010 index. Deaths were then examined for cases both where the substance was and was not found in association with other substances. This ratio (sole to all mentions; S/A) was then calculated for deaths in the period 1993 to 2016. This new measure of fatal toxicity, expressed by S/A, was well-correlated with the index L
n (T
f) of the original reference compounds. The calculation of S/A was then extended to a group of new psychoactive substances where insufficient prevalence or seizure data were available to directly determine a value of T
f by interpolation of a graph of T
f versus S/A. Benzodiazepine analogues had particularly low values of S/A and hence T
f. By contrast, γ-hydroxybutyrate/γ-butyrolactone, α-methyltryptamine, synthetic cannabinoid receptor agonists and benzofurans had a higher fatal toxicity.
AB - An index of fatal toxicity for new psychoactive substances has been developed based solely on information provided on death certificates. An updated index of fatal toxicity (T
f), as first described in 2010, was calculated based on the ratio of deaths to prevalence and seizures for the original five substances (amphetamine, cannabis, cocaine/crack, heroin and 3,4-methylenedioxymethylamphetamine)
*. These correlated well with the 2010 index. Deaths were then examined for cases both where the substance was and was not found in association with other substances. This ratio (sole to all mentions; S/A) was then calculated for deaths in the period 1993 to 2016. This new measure of fatal toxicity, expressed by S/A, was well-correlated with the index L
n (T
f) of the original reference compounds. The calculation of S/A was then extended to a group of new psychoactive substances where insufficient prevalence or seizure data were available to directly determine a value of T
f by interpolation of a graph of T
f versus S/A. Benzodiazepine analogues had particularly low values of S/A and hence T
f. By contrast, γ-hydroxybutyrate/γ-butyrolactone, α-methyltryptamine, synthetic cannabinoid receptor agonists and benzofurans had a higher fatal toxicity.
KW - availability
KW - drug users
KW - legal highs
KW - Mortality statistics
KW - new psychoactive substances
KW - prevalence
UR - http://www.scopus.com/inward/record.url?scp=85049989821&partnerID=8YFLogxK
U2 - 10.1177/0269881118754709
DO - 10.1177/0269881118754709
M3 - Article
SN - 0269-8811
VL - 32
SP - 793
EP - 801
JO - Journal of Psychopharmacology
JF - Journal of Psychopharmacology
IS - 7
ER -